Neurotoxin Polypeptide Quantification via Antibody Complexes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to reliably distinguish and quantify the active, processed Neurotoxin polypeptide from partially processed or unprocessed forms in Clostridial Neurotoxin preparations due to similar chemical and physical properties, making it challenging to determine the exact amount of biologically active toxin in therapeutic applications.
Innovation Solution
An in vitro method using specific capture and detection antibodies to form antibody complexes with processed, partially processed, and unprocessed Neurotoxin polypeptides, allowing for the calculation of the amount of processed Neurotoxin polypeptide based on the amounts of these complexes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If chemical and physical properties are used to distinguish Neurotoxin forms, then the method is simple, but the measurement precision is insufficient to differentiate processed from unprocessed forms
Solution Approach 1:
The patent introduces antibodies as intermediary substances that specifically bind to different forms of Neurotoxin. Capture antibodies bind to processed Neurotoxin while blocking antibodies bind to unprocessed forms, enabling indirect detection that overcomes the limitation of direct chemical/physical property analysis. This mediator approach allows precise differentiation without requiring complex instrumentation.
Solution Approach 2:
The patent changes the detection parameter from direct chemical/physical properties to immunological binding characteristics. By measuring antibody binding affinity and specificity rather than inherent toxin properties, the method achieves higher precision in distinguishing between processed and unprocessed Neurotoxin forms.
2Measurement precision
If antibody-based detection is used, then the measurement precision improves, but the device complexity increases due to multiple antibodies and steps
Solution Approach 1:
The detection process is segmented into distinct functional modules: capture antibody binding step, blocking antibody binding step, and detection step. Each module performs a specific function, making the complex overall process more manageable and easier to execute with proper protocol standardization.
Solution Approach 2:
The patent uses multiple copies of different antibodies (capture antibodies and blocking antibodies) that recognize different epitopes on the Neurotoxin. This multi-copy approach with different specificities enables precise differentiation while the antibodies themselves perform the complex recognition work, simplifying the operational procedure.
3Measurement precision
If specific capture antibodies binding to light chain are used, then the detection precision improves, but the manufacturing precision requirements increase for antibody production
Solution Approach 1:
The capture antibodies are designed to recognize conserved epitopes on the light chain that are present across different Neurotoxin serotypes. This universal binding capability allows a single antibody to function across multiple applications, reducing the need for highly specialized, serotype-specific antibodies and thereby lowering manufacturing precision requirements while maintaining detection precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a reliable and accurate determination of the processed Neurotoxin polypeptide, enhancing the quality control of Neurotoxin preparations by quantifying the biologically active toxin, ensuring consistent therapeutic effects.
Implementation Method 1
contacting a first portion of said solution comprising processed Clostridial Neurotoxin polypeptide and partially processed and/or unprocessed Clostridial Neurotoxin polypeptide, with a first capture antibody which specifically binds to the light chain of processed, partially processed and unprocessed Clostridial Neurotoxin polypeptide under conditions which allow for binding of said first capture antibody to said light chain of processed, partially processed and unprocessed Clostridial Neurotoxin polypeptide, thus forming a first antibody complex
Implementation Method 2
contacting said first antibody complex with a detection antibody which specifically binds to the heavy chain of said processed, unprocessed and partially processed Clostridial Neurotoxin polypeptide in the antibody complex formed in step a), whereby a first detection complex is formed
Implementation Method 3
contacting a second portion of said solution comprising processed Clostridial Neurotoxin polypeptide and partially processed and/or unprocessed Clostridial Neurotoxin polypeptide, with a second capture antibody which specifically binds to the linker of said partially processed or unprocessed Clostridial Neurotoxin polypeptide under conditions which allow for binding of said second capture antibody to said partially processed or unprocessed Clostridial Neurotoxin polypeptide, wherein said second capture antibody specifically binds to a peptide epitope consisting of an amino acid sequence as shown in any one of SEQ ID NO: 1 to 16, thus forming a second antibody complex
Implementation Method 4
contacting said second antibody complex with a detection antibody which is different from the detection antibody in step b) and which specifically binds to the antibody complex formed in step c), whereby a second detection complex is formed
Data Source
AI summary
The present invention pertains to the field of tools for ensuring manufacture of polypeptides and quality control. Specifically, it relates to a method for determining of the amount of processed (active) Neurotoxin polypeptide in a solution comprising processed Neurotoxin polypeptide and partially processed or unprocessed Neurotoxin polypeptide. The present invention relates further to a device for determining said amount and a kit adapted to carry out the method of the present invention.